口服莫沙必利治疗功能性消化不良的随机对照试验

被引:9
作者
达四平
赵晓晏
李宜辉
苏红媛
邓居有
机构
[1] 第三军医大学附属新桥医院消化内科!重庆
[2] 第三军医大学附属新桥医院核医学科!重庆
关键词
消化不良/药物疗法; 胃肠活动; 胃排空; 药代动力学;
D O I
10.16016/j.1000-5404.2001.05.050
中图分类号
R969 [临床药理学];
学科分类号
摘要
目的 观察新型促胃肠动力药莫沙必利 (胃 5 HT4受体促进剂 )对功能性消化不良 (FD)的随机对照试验。方法 FD患者 42例 ,随机分为试验组 (2 1例 ,服枸橼酸莫沙必利片 )和对照组 (2 1例 ,服吗叮啉片 )。采用GCP标准 ,双盲法观察 ,在实验开始前、服药第 1 4、2 8天记录症状变化及副作用发生情况。随机抽取部分患者于实验开始前和结束时做99MTc胃排空试验。结果 莫沙必利对FD症状的疗效与吗叮啉组相当 (P >0 .0 5 )。99MTc胃排空测定发现莫沙必利组治疗后的半排时间 (45 .0 5± 1 2 .2 1 )min缩短 ,1 2 0min残留率 (2 9.73%± 8.5 1 % )减少 (P <0 .0 5 ) ,两组病例未发现毒副反应。结论 莫沙必利对于FD疗效良好 ,对胃排空延迟有良好疗效 ,安全度高。
引用
收藏
页码:593 / 595
页数:3
相关论文
共 12 条
[1]  
Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Rosenstock S,Kay L,Rosenstock C,et al. Gut . 1997
[2]  
A dual-tracer method for studying intragastric distribution and gastric emptying of solids and liquids in functional dyspepsia. Kairemo K J,Koskenpato J,Korppi Tommola E T,et al. Nuclear Medicine Communications . 1998
[3]  
Dynamic antral scintigraphy to characterize gastric antral motility in functional dyspepsia. Urbain J L,Vekemans M C,Parkman H,et al. The Journal of Nuclear Medicine . 1995
[4]  
A quantitative analysis of symptoms of non-ulcer dyspepsia as related to age, pathology, and Helicobacter infection. Lai S T,Fung K P,Ng F H,et al. Scandinavian Journal of Gastroenterology . 1996
[5]  
Dyspepsia: a reappraisal problem. Andriulli A,Gullini S,Guslandi M,et al. Recenti Progressi in Medicina . 1998
[6]  
Pharmacological effects of the gastroprokinetic agent mosapride citrate. Yoshida N. Nippon Yakurigaku Zasshi . 1999
[7]  
Ability of mosapride to bind to 5-HT4 receptor in the human stomach. Sakurai-Yamashita Y,Takada K,Takemura K,et al. Japanese Journal of Pharmacology . 1999
[8]  
The effect of mosapride,a novel prokinetic,on acid reflux variables in patients with gas-tro-oesophageal reflux disease. Ruth M,Hamelin B,Rohss K,et al. Alimentary Pharmacology and Therapeutics . 1998
[9]  
Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro : implications for proarrhythmic potential. Carlsson L,Amos G J,Andersson B,et al. Journal of Pharmacology and Experimental Therapeutics . 1997
[10]  
Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles. Kii Y,Ito T. Journal of Cardiovascular Pharmacology . 1997